Re: the downstream processing SS,
”This study identified some promising aspects to the downstream strategy, however further work is required before this can be properly evaluated as a viable option.”
I revert back to the original announcement re the SS (21st of October 2019)
”In addition to realising a premium price for these products, the potential to produce it on site at Goulamina could significantly reduce overall product transport costs for the project because of their lower volume compared with spodumene concentrate.”
so in other words, cards are being held to the chest on this one. Results in the DFS have surpassed my hopes, and would you believe there’s still the possibility to increase premiums and reduced costs.
Firefinch... on fire!
- Forums
- ASX - By Stock
- FFX
- Ann: GOULAMINA LITHIUM PROJECT DEFINITIVE FEASIBILITY STUDY
Ann: GOULAMINA LITHIUM PROJECT DEFINITIVE FEASIBILITY STUDY, page-15
-
- There are more pages in this discussion • 117 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online